Crst Syndrome (Calcinosis Cutis, Raynaud's Phenomenon, Sclerodactyly, and Telangiectasia) Associated with Autoimmune Hepatitis

Internal Medicine

Volumn 34, Issue 1, 1995, Pages 6-9

  Ishikawa, Mamoru ^a   Okada, Jun ^a   Kondo, Hirobumi ^a   Shibuya, Akitaka ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

anticentromere antibody; chronic active hepatitis

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BLOOD; CENTROMERE; CHRONIC HEPATITIS; FEMALE; FINGER; GANGRENE; HUMAN; IMMUNOLOGY; PATHOLOGY; SYNDROME CREST;

ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; CENTROMERE; CREST SYNDROME; FEMALE; FINGERS; GANGRENE; HEPATITIS, CHRONIC; HUMAN; MIDDLE AGE;

EID: 0029206110     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.34.6     Document Type: Article

References (19)

1. Winterbuaer R: Multiple telangiectasia, Raynaud's phenomenon, sclerodactyly and subcutaneous calcinosis: A syndrome mimicking hereditary hemorrhagic telangiectasia. Bull Johns Hopkins Hosp 114: 361, 1964.
2. Moroi Y, Peebles C, Frizler M, Steingerwald J, Tan E: Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA 77: 1627, 1980.
3. Ferri C, Bernini L, Cecchetti R, et al: Cutaneous and serologic subsets of systemic sclerosis. J Rheumatol 18: 1826, 1991.
4. Bennett R: Scleroderma and overlap syndrome. Rheum Dis Clin North Am 16: 185, 1990.
5. Manns M: Autoimmune diseases of the liver. Clin Lab Med 12: 25, 1992.
6. Yabe H, Noma K, Tada N, Mochizuki S, Nagano M: A case of CREST syndrome with rapidly progressive liver damage. Intern Med 31: 69, 1992.
7. Scheuer PJ: Chronic hepatitis, in: Liver Biopsy Interpretation. Fourth Ed. Scheuer PJ, Ed. Bailliere Tindall, London, 1987, p. 113.
8. Numata K, Imai R, Yamada H, Takamori K: A case of CREST syndrome associated with lupoid type autoimmune hepatitis and chronic thyroiditis. Rinshou Hifuka 43: 1125, 1989 (in Japanese).
9. Okano T, Hirakata M, Mimori T, Akizuki M: Frequency of anti-centromere antibodies in the anti-mitochondrial antibody positive sera. Rinsho Byori 37: 1367, 1989 (in Japanese).
10. Nishioka M, Watanabe S, Kagawa H, et al: Heterogeneity of antinuclear antibodies in autoimmune hepatic diseases. Annual Report of the Ministry of Health and Welfare - Research Committee of Intractable Hepatitis 267, 1988 (in Japanese).
11. Tan EM, Cohen AS, Fries JF, et al: 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271, 1982.
12. Miller MH, Littlejohn GO, Davidson A, Jones B, Topliss DJ: The clinical significance of the anticentromere antibody. Br J Rheumatol 26: 17, 1987.
13. Powell FC, Schroeter AL, Dickson ER: Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases. Q J Med 62: 75, 1987.
14. Clup KS: Autoimmune association of primary biliary cirrhosis. Mayo Clin Proc 57: 365, 1982.
15. Bernstein RM, Callender ME, Neuberger JM, Hughes GRV, Williams R: Anticentromere antibody in primary biliary cirrhosis. Ann Rheum Dis 41: 612, 1982.
16. Reynolds T, Denison E, Frankl H, Lieberman F, Peters R: Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasis. Am J Med 50: 302, 1971.
17. Cassani F, Bianchi FBB, Lenzi M, Volta U, Pisi E: Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. J Clin Pathol 38: 801, 1985.
18. Makinen D, Fritzler M, Davis P, Sherlock S: Anticentromere antibodies in primary biliary cirrhosis. Arthritis Rheum 26: 914, 1983.
19. Weiner E, Hildebrandt S, Senecal J, et al: Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. A prospective study. Arthritis Rheum 34: 68, 1991.